Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway

Overview of attention for article published in Journal of Hematology & Oncology, October 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 49 Dimensions

Readers on

mendeley: 46 Mendeley

Summary Policy documents Dimensions citations

So far, Dimensions has found 49 publications that cite this research output.

49

The most recent citing publications are shown below. View all 49 publications that cite this research output on Dimensions.

Pharmacological Insights: Mitochondrial ROS Generation by FNC (Azvudine) in Dalton’s Lymphoma Cells Revealed by Super Resolution Imaging

Article in Cell Biochemistry and Biophysics (March 2024)

In the Pipeline—Emerging Therapy for ALL

Book chapter (September 2023)

Targeted delivery of AZD5363 to T-cell acute lymphocytic leukemia by mSiO2-Au nanovehicles

Article in Colloids and Surfaces B Biointerfaces (August 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.